Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
94,179,674
-
Total 13F shares
-
15,234,699
-
Share change
-
-3,696,304
-
Total reported value
-
$229,128,583
-
Price per share
-
$15.04
-
Number of holders
-
60
-
Value change
-
-$94,249,206
-
Number of buys
-
24
-
Number of sells
-
23
Institutional Holders of Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) as of Q3 2019
As of 30 Sep 2019,
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,234,699 shares.
The largest 10 holders included
FMR LLC, PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., EVENTIDE ASSET MANAGEMENT, LLC, VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, VICTORY CAPITAL MANAGEMENT INC, and Opaleye Management Inc..
This page lists
60
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.